Concepedia

Chiara Maria Dellacasa

CM

22

Publications

885

Citations

17

H-Index

2007

Active since

Affiliations

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino(Current)

University of Turin

Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo

University Hospital Bonn

University of Florence

Chiara Maria Dellacasa is an author at Azienda Ospedaliera Citta' della Salute e della Scienza di Torino specializing in medicine, hematology, and pathology.

ORCID

Top concepts

Publications per year

2007–2023

22

Publications

22

A pilot study of the Histone‐Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms

Alessandro Rambaldi, Chiara Maria Dellacasa, Guido Finazzi et al. · British Journal of Haematology · 2010 · 240 citations · Full text

, , +20

The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2V617F

Vittoria Guerini, Valentina Barbui, Orietta Spinelli et al. · Leukemia · 2007 · 150 citations

, , +9

JAK2V617F allele burden and thrombosis: A direct comparison in essential thrombocythemia and polycythemia vera

Alessandra Carobbio, Guido Finazzi, Elisabetta Antonioli et al. · Experimental Hematology · 2009 · 102 citations · Full text

, , +11

Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study

Federica Martella, Marco Cerrano, Daniela Di Cuonzo et al. · Annals of Hematology · 2022 · 36 citations

, , +11

A Phase 2A study of the Histone-Deacetylase Inhibitor ITF2357 in Patients with Jak2V617F Positive Chronic Myeloproliferative Neoplasms

Alessandro Rambaldi, Chiara Maria Dellacasa, Silvia Salmoiraghi et al. · Blood · 2008 · 32 citations

Rows per page

1–5 of 22